Document is current
Any future updates will be listed below
-
Authors
Ono, Koutaro
Murase, Remi
Matsumoto, Natsumi
Kubota, Yutaro
Ishida, Hiroo
Fujita, Ken-ichi https://orcid.org/0000-0002-1575-6690
-
Clinical Trials BETA
Clinical trials referenced in this document:
umin000013939 at UMIN JapanDocuments that mention this clinical trial
Association of VEGFA and CCL4L2 polymorphisms with hand-foot skin reaction and survival of regorafenib in Japanese patients with colorectal cancer
https://doi.org/10.1007/s00280-024-04649-5
-
Funding
Funding for this research was provided by:
JSPS Grant-in-Aid for Scientific Research (19K07204)
- License Information
-
More Information
Article History
Received: 4 December 2023
Accepted: 2 February 2024
First Online: 8 March 2024
Declarations
:
: The authors declare that they have no conflict of interest.
: This study was conducted in accordance with the principles of the Declaration of Helsinki. The study protocol was approved by the Institutional Review Board of Showa University. The study was registered with the University Hospital Medical Information Network-Clinical Trials Registry for Japan on May 12, 2014 (UMIN000013939), when 6 months after the approval by the Institutional Review Board of Showa University.
: All patients gave written informed consent for the use of their peripheral blood samples and medical information for research purposes.
: All patients gave written informed consent regarding publishing their data.
